Hidden cancer hunt: Full-Body scan could spot tumors in blood clot patients
NCT ID NCT04304651
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether a detailed full-body scan called FDG PET/CT can find hidden cancers in people aged 50 and older who have had an unexplained blood clot. About 1,276 participants will get either the scan or standard cancer checks. The goal is to see if the scan catches more cancers early, which could lead to better treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
FDG PET/CT scan
What this could lead to
If successful, this could show that advanced imaging like FDG PET/CT is better at catching hidden cancers early in people with unexplained blood clots, potentially improving survival.
What could go wrong
This is a diagnostic study, not a treatment trial. The scan may miss some cancers or lead to unnecessary follow-ups. Results may not apply to younger patients or those with provoked clots.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EMBOLISM AND THROMBOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brest University Hospital
Brest, France
-
CH Agen
Agen, France
-
CH des Pays de Morlaix
Morlaix, France, 29600, France
-
CHU Angers
Angers, France
-
CHU Saint-Etienne
Saint-Etienne, France
-
CHU de Clermont-Ferrand
Clermont-Ferrand, France
-
CHU de Dijon
Dijon, France
-
CHU de Limoges
Limoges, France
-
Hopital Montfort
Ottawa, Ontario, Canada
-
Hôpital Européen Georges Pompidou
Paris, France
-
Hôpital Saint Musse - CH Toulon
Toulon, France
-
Jewish General Hospital
Montreal, Quebec, Canada
-
Ottawa Hospital Research Institute
Ottawa, Ontario, Canada
-
Sherbrooke Hospital
Sherbrooke, Canada
-
Sunnybrook Research Institute
Toronto, Ontario, Canada
-
University Health Network
Toronto, Ontario, Canada